Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the diagnosis, management, and pathogenesis of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. It covers evidence-based guidelines, cellular and molecular mechanisms of fibrosis, therapeutic translation, treatment trials with drugs like pirfenidone and nintedanib, as well as the role of myofibroblasts and epithelial-mesenchymal transition in lung fibrosis.

345
Works

How has Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis's publication output changed over time?

ScholarIQpublication output · 1998–2021

Output grew0% over the shown period — from 1 works in 1998 to 1 in 2021.

1
2
1
1
1
1
2
2
3
1
1998200920102011201220142015201820202021

What are the most-cited papers on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis?

ScholarIQmost cited works
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice Guideline
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A. Cuello‐García, Arata Azuma, Juergen Behr, Jan Brożek, Harold R. Collard, William E. Cunningham, Sakae Homma, Takeshi Johkoh, Fernando J. Martínez, Jeffrey L. Myers, Shandra Protzko, Luca Richeldi, David M. Rind, Moisés Selman, Arthur C. Theodore, Athol U. Wells, Henk C. Hoogsteden, Holger J. Schünemann
S93356601. 20151,937 Citations
Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis
Arun C. Habermann, Austin J. Gutierrez, Linh T. Bui, Stephanie L. Yahn, Nichelle I. Winters, Carla L. Calvi, Lance Peter, Mei-I Chung, Chase J. Taylor, Christopher S. Jetter, Latha Raju, Jamie Roberson, Guixiao Ding, Lori Wood, Jennifer M. S. Sucre, Bradley W. Richmond, Ana Serezani, Wyatt J. McDonnell, Simon B. Mallal, Matthew J. Bacchetta, James E. Loyd, Ciara M. Shaver, Lorraine B. Ware, Ross M. Bremner, Rajat Walia, Timothy S. Blackwell, Nicholas E. Banovich, Jonathan A. Kropski
S2737427234. 20201,131 CitationsOPEN ACCESS
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
Aryeh Fischer, Κατερίνα Αντωνίου, Kevin M. Brown, J. Cadranel, Tamera J. Corte, Roland M. du Bois, Joyce Lee, Kevin O. Leslie, David A. Lynch, Eric L. Matteson, Marta Mosca, Imre Noth, Luca Richeldi, Mary E. Strek, Jeffrey J. Swigris, Athol U. Wells, Sterling G. West, Harold R. Collard, Vincent Cottin
S4210207896. 20151,099 Citations
Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition
Jason R. Rock, Christina E. Barkauskas, Michael J. Cronce, Yan Xue, Jeffrey R. Harris, Jiurong Liang, Paul W. Noble, Brigid L.M. Hogan
Proceedings of the National Academy of Sciences. 20111,057 Citations
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
Julie A. Bjoraker, Jay H. Ryu, Mark Edwin, Jeffrey L. Myers, Henry D. Tazelaar, Darrell R. Schroeder, Kenneth P. Offord
S93356601. 19981,048 Citations

Where is Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis research published, and who funds it?

ScholarIQvenues & funding sources

TOP JOURNALS

S933566014,047
S42102078962,051
S27374272341,131
S132787887873

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis is open access?

ScholarIQopen access share
60%OPEN ACCESS
Gold
13%
Green
20%
Hybrid
0%
Bronze
27%
Closed
40%

Related on ScholarIQ

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Paper
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
Paper
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
Paper
An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease
Paper
Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Paper
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice Guideline
Paper
470M+ articles · free account